Pricing Log in Create free account

Aurinia Pharmaceuticals Inc (AUPH) vs Fortrea Holdings Inc. (FTRE)

Aurinia Pharmaceuticals Inc and Fortrea Holdings Inc. are both Biotechnology companies. Aurinia Pharmaceuticals Inc and Fortrea Holdings Inc. are of similar size ($2.2B and $2.2B). Fortrea Holdings Inc. has negative trailing earnings, so its P/E is not meaningful; Aurinia Pharmaceuticals Inc trades at 6.9×. Aurinia Pharmaceuticals Inc grew revenue faster over the last twelve months: 19.8% against −2.09%. Aurinia Pharmaceuticals Inc has the higher net margin (100.8% vs −3.18%) and the higher return on invested capital (40.8% vs −0.48%). Across the 20 metrics below, Aurinia Pharmaceuticals Inc leads on 16 and Fortrea Holdings Inc. on 4.

Valuation

Metric AUPH FTRE Biotechnology median
P/E 6.91 n/m 8.50
P/S 6.89 0.80 9.71
P/B 3.49 4.07 2.13
Price to free cash flow 12.27 10.77 20.82
EV/EBITDA 10.93 44.71 0.64
EV/Sales 5.61 1.13 9.21
Earnings yield 14.48% (4.05%) (33.15%)
Free cash flow yield 8.15% 9.29% (25.50%)

Profitability

Metric AUPH FTRE Biotechnology median
Gross margin 90.36% 19.30% 65.16%
Operating margin 45.15% (0.40%) 0.00%
Net margin 100.84% (3.18%) 0.00%
Free cash flow margin 56.20% 7.40% 0.00%
Return on equity 66.12% (15.30%) (56.36%)
Return on assets 48.52% (3.07%) (48.04%)
Return on invested capital 40.76% (0.48%) 0.00%

Growth

Metric AUPH FTRE Biotechnology median
Revenue growth (TTM) 19.76% (2.09%) 6.02%
EPS growth (last fiscal year) 5,075.00% (194.55%) 30.26%
Revenue growth, 5-year CAGR 41.38% 1.09% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AUPH FTRE Biotechnology median
Debt to equity 0.07 2.01 0.00
Current ratio 5.42 0.96 4.72
Net debt to EBITDA (2.58) 266.13 0.96

Dividend

Metric AUPH FTRE Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AUPH FTRE Biotechnology median
Market cap 2.23b 2.16b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack